Loading...
Loading...
Biotech innovations, life sciences research, and bioengineering
6 Problem Statements in this Domain (5 Standard + 1 Open Innovation)
Groundwater contamination by arsenic, fluoride, and pesticide residues affects large populations across several Indian states, but routine testing requires laboratory water analysis (AAS, ICP-MS, chromatography) that is slow, costly, and geographically inaccessible for the density of wells that would need regular monitoring. Communities frequently continue drawing from contaminated wells for years before test results reach them, if testing happens at all. A field-usable biosensor-based approach (e.g., enzyme inhibition, whole-cell reporter, or aptamer-based sensing) could enable rapid on-site screening, but must reliably discriminate target contaminants at regulatory-relevant concentrations amid the complex, variable chemistry of real groundwater — not idealized lab water.
Effective crop disease management often depends on knowing not just that a pathogen is present but which strain/race — since resistant varieties and fungicide choices are often strain-specific, and misidentification leads to ineffective, wasted treatment across an entire growing season. Full genomic sequencing can resolve this precisely but is far too slow and expensive for real-time field decision-making during an active outbreak. The challenge is achieving useful strain-level (not just species-level) differentiation using field-deployable, rapid, low-cost molecular or immunological methods, when outbreaks require decisions within days, not the weeks a sequencing pipeline requires.
Small-scale fermentation/bioreactor units producing probiotics, enzymes, or biofertilizers are highly sensitive to temperature and agitation consistency, but many operate in facilities with unstable grid power and significant ambient temperature swings across seasons — conditions that commercial bioreactor control systems (designed for stable industrial environments) are not built to handle gracefully. Batch failures from uncontrolled temperature excursions represent significant, recurring economic loss for small producers who cannot afford industrial-grade backup infrastructure.
Wastewater treatment plants, especially those receiving pharmaceutical manufacturing or hospital effluent, are known reservoirs for antibiotic-resistant bacteria and resistance genes that can re-enter waterways and the food chain, yet routine effluent monitoring in India rarely screens for resistance markers — only for standard chemical/biological oxygen demand parameters. Identifying which treatment stages fail to reduce resistance gene load (rather than just bacterial count) requires molecular-level assessment that current municipal monitoring infrastructure is not equipped to perform routinely or affordably.
Sickle cell disease has a disproportionately high prevalence in several tribal populations in central and western India, and large-scale screening is a stated national health priority, but the confirmatory gold-standard test (HPLC/electrophoresis) requires centralized laboratory infrastructure inaccessible to many tribal and forest-belt communities. Existing low-cost point-of-care solubility tests exist but suffer from meaningful false-positive/negative rates and cannot reliably distinguish trait (carrier) from disease status, which matters greatly for counseling and clinical management.
Have your own innovation in Biotechnology & Life Sciences? Build your own computational biology tool, biosensor device, environmental bioremediation technique, genomic analysis pipeline, enzymatic process optimization, or bioinformatics platform.